-
ADV: A Study of Methotrexate Efficacy, Adverse Events and Folic Acid Regimen in Pediatric Patients with Plaque Psoriasis
Time of Update: 2022-08-16
Acta Derm Venereol 2022 May 23;Source: Bruins F, Van Acht M, Bronckers I, Real-world Methotrexate Use in a Prospective Cohort of Paediatric Patients with Plaque Psoriasis: Effectiveness, Adverse Events and Folic Acid Regimen.
-
6 kinds of Chinese patent medicines commonly used in rheumatoid, you must know!
Time of Update: 2022-08-16
Indication syndrome: Tongbiling tablet mainly treats rheumatism invasion syndrome, rheumatism invasion type is mostly swelling and pain of muscles, bones and joints, but there is no local cold and heat, abnormal skin color, and no preference for warmth Or intolerance to cold, pale red tongue, greasy coating, and tight pulse are the main clinical features .
-
2022 Roche Osteoporosis Academic Salon - Watch the live broadcast to get 100 points and 99 guides for free!
Time of Update: 2022-08-16
leave a message here Two easy steps to get guide and watch liveguideStep 1: Scan the code to register the applet, pay attention to select the identity and fill in the information Step 2: Scan the code to receive after filling in the information for the registration of the appletStep 2: After filling in the information in the mini program registration , scan the code to receive the information.
-
Two or three things about scleroderma: "disfigured" disease, "loving" women, what to do?
Time of Update: 2022-08-16
How does TCM treat scleroderma?Traditional Chinese medicine believes that the cause of "pigmentation" is due to the invasion of exogenous wind, cold and dampness pathogens, and the internal cause of deficiency of spleen and kidney yang, and the disharmony of qi and blood .
-
Immune cytokines and systemic sclerosis
Time of Update: 2022-08-16
This article was originally created by the "Qinghe Health Alliance" platformThis article was originally created by the "Qinghe Health Alliance" platform This article was originally created by the "Qin
-
Rheumatology: Evidence of subclinical atherosclerosis in eosinophilic granulomatosis with polyangiitis (EGPA)
Time of Update: 2022-08-16
No significant correlations were found between CCA-IMT, ANCA status, other clinical features, and treatment regimens were comparableConclusions: Ultrasound markers of subclinical atherosclerosis were increased in patients with EGPA compared with controls , independent of traditional cardiovascular risk factors .
-
Hydroxychloroquine may have preventive effect on cardiovascular disease in rheumatic diseases
Time of Update: 2022-08-16
Data in recent years suggest that HCQ may have other beneficial effects beyond its ability to control disease activityIt has been investigated whether hydroxychloroquine treatment is associated with major adverse cardiovascular events (MACE) (myocardial infarction, ischemic stroke, or cardiovascular-related death) in patients with cutaneous lupus erythematosus (CLE) or systemic lupus erythematosus (SLE) .
-
In the mid-summer season, probiotics help you improve immunity and disease prevention
Time of Update: 2022-08-16
Some patients with fever may feel that even if they sweat, the fever will not subside and other characteristics of fever and coldModern medicine also believes that summer is a period of vigorous growth and reproduction of bacteria, viruses and other microorganisms.
-
ARD: Tofacitinib and Risk of Cardiovascular Outcomes: Results of the Safety of Tofacitinib in Usual Care Patients with Rheumatoid Arthritis (STAR-RA) Study
Time of Update: 2022-08-16
Objectives: Recent results from the " ORAL Surveillance" trial have raised concerns about the cardiovascular safety of tofacitinib in patients with rheumatoid arthritis (RA) . The research team furthe
-
Ways to Manage Rheumatoid Arthritis Pain
Time of Update: 2022-08-16
Opioid pain relievers:Opioid pain relievers:Opioids are mainly suitable for patients with moderate to severe chronic pain who use NSAIDs and other poor efficacy, or cannot tolerate the adverse reactions of gastrointestinal tract, cardiovascular and other adverse reactions caused by NSAIDs .
-
A&R: Efficacy of a short-term bridging strategy with different doses of prednisolone on imaging and clinical outcomes in active early rheumatoid arthritis
Time of Update: 2022-08-16
. Methods: Adult RA patients with moderate / high disease activity from one rheumatology hospital and 23 rheumatology treatment centers were randomized (1:1:1) to 60 mg (high dose, HDP ) and 10 mg daily Prednisolone (low dose, LDP , tapering to 0 mg over 12 weeks ) or placebo .
-
Edamame is paired with wine, gout often occurs!
Time of Update: 2022-08-16
Eating "beans" is important for goutEating "beans" is important for goutAlthough the purine content of soy products is not high, eating right can not only supplement nutrition, but also not increase uric acid .
-
A&R: choroid plexus infiltrating T cells drive neuropsychiatric lupus in mice
Time of Update: 2022-08-16
42252 leave a message here Objective : T cells are crucial in the pathogenesis of systemic lupus erythematosus (SLE) by secreting inflammatory cytokines, helping autoantibody production, and forming autoreactive memory T cells .
-
ARD: EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome
Time of Update: 2022-08-16
Purpose : For gout, vasculitis, systemic sclerosis (SSc) , myositis, mixed connective tissue disease (MCTD) , Sjögren's syndrome (SS) , systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) Develop recommendations for cardiovascular risk (CVR) management .
-
JEADV: 1-year effect study of Guselkumab in the treatment of psoriasis
Time of Update: 2022-08-16
J Eur Acad Dermatol Venereol 2022 May 15Source: Gerdes S, Asadullah K, Hoffmann M, Real-world evidence from the non-interventional, prospective, German multicentre PERSIST study of patients with psoriasis after 1 year of treatment with guselkumab.
-
ARD: Baricitinib in recurrent giant cell arteritis: a 52-week prospective open-label pilot study
Time of Update: 2022-08-16
Methods We conducted a prospective, open-label pilot study of baricitinib ( 4 mg/ day) with graded glucocorticoids ( GC ) and accelerated tapering in patients with recurrent GCA .
-
Biologics can dramatically improve quality of life for tonic patients, 'greatest work' isn't just in the arts
Time of Update: 2022-08-16
The application of combined vascular biologics in AS (the grapevine said that Jay Chou used gram)Biologics have irreplaceable advantages for ankylosing spondylitisBiologics have irreplaceable advantages in ankylosing spondylitis Biologics have irreplaceable advantages in ankylosing spondylitis Fast onset, can quickly relieve joint pain and swelling; Inhibition of bone destruction is better than traditional disease-modifying anti-rheumatic drugs; The drug is more targeted and can precisely block tumor necrosis factor, which can play a key role in the important link of pathogenesis .
-
ARD: Tocilizumab in New-Onset Polymyalgia Rheumatica (PMR-SPARE): A Phase 2/3 Randomized Controlled Trial
Time of Update: 2022-08-16
Conclusions In patients with new-onset polymyalgia rheumatica who received rapid glucocorticoid tapering, tocilizumab was superior to placebo for sustained glucocorticoid-free remission, time to relapse, and cumulative glucocorticoid dose .
-
Urine routine protein is negative and urine microalbumin is high, the reason is...
Time of Update: 2022-08-16
Therefore, the urine sample was first examined and found to have a cloudy appearance, as shown in the following figure:Because the sensitivity of urine microalbumin determination is higher than that of urine dry chemical protein determination, it is common sense that the urine microalbumin is slightly elevated and the urine routine protein is negative in the early stage of kidney injury.
-
Hydroxychloroquine in the eyes of "systemic rheumatoid lupus"
Time of Update: 2022-08-16
. New methods such as computer-controlled perimeter and optical coherence tomography (OCT) enable early detection of damage caused by the use of HCQ, which has led to changes in dosing recommendations and monitoring of patients undergoing treatment, as new methods suggest that receiving lower doses of patients experience no retinal damage at all when receiving higher doses or long-term cumulative therapy .
